Most Clicked StoriesMore >


Goodwin teams up with Minn. foundation to develop opioid addiction vaccines

BIO SmartBrief | Mar 23, 2017

Goodwin Biotechnology and the Minneapolis Medical Research Foundation have entered into a collaboration to develop Goodwin's two opioid addiction vaccines. A three-year grant from the National Institute on Drug Abuse will fund the research. BioPharmaReporter.com (03/22)


Regeneron teams up with Biobank, GSK to sequence gene data

BIO SmartBrief | Mar 24, 2017

Tesaro's ovarian cancer drug gets FDA nod

BIO SmartBrief | Mar 28, 2017

Parkinson's disease drug from Newron wins FDA nod

BIO SmartBrief | Mar 22, 2017

FDA OKs opioid-induced constipation drug

BIO SmartBrief | Mar 27, 2017

Novartis licenses 2 aging-related drugs to PureTech Health subsidiary

BIO SmartBrief | Mar 27, 2017

Fast-track status granted for Duchenne muscular dystrophy drug

BIO SmartBrief | Mar 28, 2017

X-Chem partners with Ono on cancer drug-discovery programs

BIO SmartBrief | Mar 22, 2017

Rare skin cancer drug from Merck, Pfizer wins FDA nod

BIO SmartBrief | Mar 24, 2017

Actinium gets EMA nod for AML drug

BIO SmartBrief | Mar 23, 2017


Find BIO SmartBrief Issues by Date:



BIO News More >


Airgas

BIO SmartBrief | Mar 29, 2017

2017 BIO International Convention in San Diego

BIO SmartBrief | Mar 29, 2017

Are you looking for top biotech talent? Or looking for a biotech job?

BIO SmartBrief | Mar 28, 2017

Nikon

BIO SmartBrief | Mar 28, 2017

Unifirst -- Latest version

BIO SmartBrief | Mar 27, 2017




Sign up for BIO SmartBrief



Designed specifically for biotechnology industry professionals like you, BIO SmartBrief is a FREE daily e-mail newsletter. It provides the latest news and information you need to stay informed about important biotech issues. Learn more